Login

Joseph Chen, CEO of Renren Inc., discusses the Chinese social-networking site's recent $855 million completion. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Understanding Recent Market Volatility and Making Smart Investment Decisions | Ben Smith, Founder, Cove Financial Planning, LLC.
00:10:00
We strive to excel in everything we do.|Abrielle Rosenthal, Chief Sustainability Officer,TowerBrook Capital Partners, L.P.
00:10:00
Strategic Investment Insights: Analyzing Alibaba, Political Dynamics, and Central Bank Easing | Hamish Douglass , CIO , Magellan Asset Management Limited .
00:10:00
invest and support founders from seed until the later stages|Deven Parekh,Managing Director,Insight Partners
00:10:00
Mission is to partner with entrepreneurs solving big problems|Ray Lane,Managing Partner,GreatPoint Ventures
00:10:00
relentless mission to change the world of finance|Micky Malka,Ribbit,Ribbit Capital
00:10:00
Securities offered through IFP Securities, LLC, while Starbucks' CEO discusses business strategy in a separate segment.
00:10:00
CAE Inc. (TSX:CAE) is captured in a filming session dated September 20, 2016, accessible through
00:10:00
Biotech CEO presents promising clinical trial results and upcoming milestones |Helen Tuvesson , CEO, Active Biotech AB
00:10:00
Overview of TLC Lithium Project: Resource and Mining Details
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Adventure Box CEO Christopher Kingdon Discusses Q1 Report and Rising Interest Amid Pandemic | Christopher Kingdon, CEO, Adventure Box Technology AB.

© 2026 Nehu